NJ-based Johnson & Johnson plans to have COVID-19 vaccines for 100 million Americans by April
New Brunswick-based Johnson & Johnson is planning to have enough COVID-19 vaccines for 100 million Americans by April.
•
Jan 22, 2021, 12:19 PM
•
Updated 1,281 days ago
Share:
More Stories
0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
32ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago
Murphy administration: No plans to implement any COVID-19 restrictions
316ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
317ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
319ds ago0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
32ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds agoMurphy administration: No plans to implement any COVID-19 restrictions
316ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
317ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
319ds agoNew Brunswick-based Johnson
& Johnson is planning to have enough COVID-19 vaccines for 100 million
Americans by April.
The company is currently
conducting a trial to make sure its vaccine is safe and effective.
Dr. Anthony Fauci says it’s
close to seeking an emergency use authorization from the FDA.
Johnson & Johnson's
vaccine is a single shot and doesn't need to be stored in temperatures as cold as Pfizer and Moderna shots.